Publications by authors named "Daniel McMasters"

Claim this Profile
S
Smallest Maximum Intramolecular Distance: A Novel Method to Mitigate Pregnane Xenobiotic Receptor Activation.
Michael J Bower, Alex M Aronov, Thomas Cleveland, Niresh Hariparsad, Georgia B McGaughey, Daniel R McMasters

J Chem Inf Model· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge-Based Approaches to Off-Target Screening.
Daniel R McMasters

Methods Enzymol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension.
Scott B Hoyt, Jerry Taylor, Clare London, Amjad Ali, Feroze Ujjainwalla, Daniel McMasters

Bioorg Med Chem Lett· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
Jiayi Xu, Songnian Lin, Robert W Myers, George Addona, Joel P Berger, Daniel R McMasters

Bioorg Med Chem Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus.
Jiayi Xu, Songnian Lin, Robert W Myers, Maria E Trujillo, Michele J Pachanski, Daniel R McMasters

Bioorg Med Chem Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension.
Whitney L Petrilli, Scott B Hoyt, Clare London, Daniel McMasters, Andreas Verras

ACS Med Chem Lett· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting Therapeutic Resistance to ERK Inhibition.
Sharda Jha, Erick J Morris, Alan Hruza, My Sam Mansueto, Gottfried K Schroeder, Daniel McMasters

Mol Cancer Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.
Scott B Hoyt, Whitney Petrilli, Clare London, Gui-Bai Liang, Jim Tata, Daniel McMasters

ACS Med Chem Lett· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.
Scott B Hoyt, Min K Park, Clare London, Yusheng Xiong, Jim Tata, Daniel McMasters

ACS Med Chem Lett· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
eCounterscreening: using QSAR predictions to prioritize testing for off-target activities and setting the balance between benefit and risk.
Robert P Sheridan, Daniel R McMasters, Johannes H Voigt, Mary Jo Wildey

J Chem Inf Model· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitors.
Richard C A Isaacs, Christina L Newton, Kellie J Cutrona, Swati P Mercer, Linda S Payne, Daniel R McMasters

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy.
Kobporn L Howell, Robert J DeVita, Margarita Garcia-Calvo, Roger D Meurer, JeanMarie Lisnock, Daniel R McMasters

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivo.
Denise M Kenski, Abby J Cooper, Jenny J Li, Aarron T Willingham, Henry J Haringsma, Daniel R McMasters

Nucleic Acids Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel class of isoxazoline voltage gated sodium channel blockers.
Pengcheng P Shao, Feng Ye, Ann E Weber, Xiaohua Li, Kathryn A Lyons, Daniel R McMasters

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain.
Pengcheng P Shao, Feng Ye, Ann E Weber, Xiaohua Li, Kathryn A Lyons, Daniel R McMasters

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QSAR models for predicting the similarity in binding profiles for pairs of protein kinases and the variation of models between experimental data sets.
Robert P Sheridan, Kiyean Nam, Vladimir N Maiorov, Daniel R McMasters, Wendy D Cornell

J Chem Inf Model· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spiroimidazolidinone NPC1L1 inhibitors. 1: Discovery by 3D-similarity-based virtual screening.
Daniel R McMasters, Margarita Garcia-Calvo, Vladimir Maiorov, Margaret E McCann, Roger D Meurer

Bioorg Med Chem Lett· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pH on plasma protein binding in equilibrium dialysis.
Christopher J Kochansky, Daniel R McMasters, Ping Lu, Kenneth A Koeplinger, Haley H Kerr

Mol Pharm· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular loop C of NPC1L1 is important for binding to ezetimibe.
Adam B Weinglass, Martin Kohler, Uwe Schulte, Jessica Liu, Emmanuel O Nketiah, Daniel R McMasters

Proc Natl Acad Sci U S A· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
Richard C A Isaacs, Mark G Solinsky, Kellie J Cutrona, Christina L Newton, Adel M Naylor-Olsen, Daniel R McMasters

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guest editorial for special issue on "ADME and Physical Properties".
Daniel R McMasters

J Comput Aided Mol Des· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.
Rhonda A Torres, Kenneth R Korzekwa, Daniel R McMasters, Christine M Fandozzi, Jeffrey P Jones

J Med Chem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and HCV inhibitory properties of 9-deaza- and 7,9-dideaza-7-oxa-2'-C-methyladenosine.
Gabor Butora, David B Olsen, Steven S Carroll, Daniel R McMasters, Christoph Schmitt

Bioorg Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of recombinant cytochrome P450 isoforms 2D6 and 2C9 by diverse drug-like molecules.
Daniel R McMasters, Rhonda A Torres, Susan J Crathern, Deborah L Dooney, Robert B Nachbar

J Med Chem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonists.
Ian M Bell, Rodney A Bednar, John F Fay, Steven N Gallicchio, Jerome H Hochman, Daniel R McMasters

Bioorg Med Chem Lett· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis